Peripheral Neuropathy Trial, Recruiting (NCT07293780)

Peripheral Neuropathy Trial, Recruiting NCT07293780 Sponsor: Ankara Etlik City Hospital Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT07293780 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had at least 12 months pass since the event that caused their condition
People whose pain meets the International Pain Working Group's definition of central neuropathic pain below the level of their injury or lesion, and who have had this pain for at least 6 months
People between 18 and 65 years of age
People whose pain is not caused by other conditions such as rheumatological diseases or diabetes
People whose pain remains above a score of 4 on a standard pain scale (VAS) despite having already tried maximum doses of pain medications (including anticonvulsants, antidepressants, and narcotics), exercise, and physical therapy, with their kidney function and other health conditions taken into account

Who may not be able to join:

People with a history of epilepsy
People who have a metal implant in the scalp
People who have a cochlear implant (a device implanted in the ear for hearing)
People who have a spinal cord stimulator device
People who have a pacemaker
People with a diagnosed psychiatric illness
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 0312 797 00 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07293780

Sponsor: Ankara Etlik City Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +90 0312 797 00 00

More information: https://clinicaltrials.gov/study/NCT07293780

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had at least 12 months pass since the event that caused their condition
People whose pain meets the International Pain Working Group's definition of central neuropathic pain below the level of their injury or lesion, and who have had this pain for at least 6 months
People between 18 and 65 years of age
People whose pain is not caused by other conditions such as rheumatological diseases or diabetes
People whose pain remains above a score of 4 on a standard pain scale (VAS) despite having already tried maximum doses of pain medications (including anticonvulsants, antidepressants, and narcotics), exercise, and physical therapy, with their kidney function and other health conditions taken into account

Who may not be able to join:

People with a history of epilepsy
People who have a metal implant in the scalp
People who have a cochlear implant (a device implanted in the ear for hearing)
People who have a spinal cord stimulator device
People who have a pacemaker
People with a diagnosed psychiatric illness
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ankara Etlik City Hospital

Registry

ClinicalTrials.gov

Start date

15 December 2025

Est. completion

1 August 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

visual analog scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov